A urine test that uses nanoparticles to detect thrombin, a key factor in the causation of blood clots, may help monitor patients at high risk for clots, according to a study undertaken at Massachusetts Institute of Technology.
The study, published in the journal ACS Nano, could provide a new form of testing in an area of need.
"Some patients are at more risk for clotting, but existing blood tests are not consistently able to detect the formation of new clots," said Sangeeta Bhatia, senior author of the paper.
Last year, Bhatia developed tech used to detect colorectal cancer, adding that a similar procedure works for detecting blood clots.
"[W]e took the test we had developed before, which is an injectable nanoparticle, and made it a thrombin sensor," Bhatia said.
Bhatia plans on launching a company with the aim of commercializing the technology.
For comments and feedback contact: editorial@rttnews.com
Health News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.